Tilray Inc (TLRY) - Total Liabilities

Latest as of February 2026: CA$549.12 Million CAD ≈ $397.22 Million USD

Based on the latest financial reports, Tilray Inc (TLRY) has total liabilities worth CA$549.12 Million CAD (≈ $397.22 Million USD) as of February 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Tilray Inc cash flow conversion to assess how effectively this company generates cash.

Tilray Inc - Total Liabilities Trend (2012–2025)

This chart illustrates how Tilray Inc's total liabilities have evolved over time, based on quarterly financial data. Check TLRY asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Tilray Inc Competitors by Total Liabilities

The table below lists competitors of Tilray Inc ranked by their total liabilities.

Company Country Total Liabilities
Thai Vegetable Oil Public Company Limited
BK:TVO-R
Thailand ฿3.59 Billion
China Master Logistics Co Ltd
SHG:603967
China CN¥1.55 Billion
Cullinan Oncology LLC
NASDAQ:CGEM
USA $32.76 Million
Beijing Jingcheng Machinery Electric Co Ltd
SHG:600860
China CN¥1.94 Billion
Media and Games Invest PLC
F:M8G
Germany €746.49 Million
Velocity Financial Llc
NYSE:VEL
USA $6.32 Billion
Zhejiang Feida Environmental Science & Technology Co Ltd
SHG:600526
China CN¥7.63 Billion
Baotek Industrial Materials Ltd
TWO:5340
Taiwan NT$607.05 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Tilray Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Tilray Inc (TLRY) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.79 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.35 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.26 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tilray Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tilray Inc (2012–2025)

The table below shows the annual total liabilities of Tilray Inc from 2012 to 2025.

Year Total Liabilities Change
2025-05-31 CA$584.75 Million
≈ $423.00 Million
-24.89%
2024-05-31 CA$778.49 Million
≈ $563.15 Million
-20.34%
2023-05-31 CA$977.32 Million
≈ $706.98 Million
-3.08%
2022-05-31 CA$1.01 Billion
≈ $729.41 Million
-35.37%
2021-05-31 CA$1.56 Billion
≈ $1.13 Billion
+227.82%
2020-05-31 CA$475.89 Million
≈ $344.25 Million
-9.11%
2019-05-31 CA$523.61 Million
≈ $378.77 Million
+380.55%
2018-05-31 CA$108.96 Million
≈ $78.82 Million
+248.65%
2017-05-31 CA$31.25 Million
≈ $22.61 Million
+3118.36%
2016-05-31 CA$971.04K
≈ $702.44K
+27.40%
2015-05-31 CA$762.17K
≈ $551.35K
+7204.72%
2014-05-31 CA$10.43K
≈ $7.55K
0.00%
2013-05-31 CA$10.43K
≈ $7.55K
-5.80%
2012-05-31 CA$11.08K
≈ $8.01K
--

About Tilray Inc

TO:TLRY Canada Drug Manufacturers - Specialty & Generic
Market Cap
$706.51 Million
CA$976.68 Million CAD
Market Cap Rank
#10803 Global
#304 in Canada
Share Price
CA$8.38
Change (1 day)
-1.06%
52-Week Range
CA$0.50 - CA$19.12
All Time High
CA$26.00
About

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and… Read more